Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab, Dexamethasone, and Mycophenolate Mofetil in Persistent/Chronic ITP
NCT02649504Phase 3Withdrawn
- Sponsor
- Weill Cornell Medicine
- Start
- Dec 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mycophenolate mofetil in immune thrombocytopenia (ITP), sponsored by Weill Cornell Medicine. Planned start Dec 2016; status: withdrawn.
02
Drugs
mycophenolate mofetil
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT02649504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02649504.